CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

ATRA's Free Cash Flow Growth by Quarter and Year

Atara Biotherapeutics,'s Free Cash Flow results by quarter and year




ATRA Free Cash Flow (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - -57.42 -24.94 -36.75
III Quarter September - -48.10 -20.23 -11.54
II Quarter June - -39.43 -20.30 -12.49
I Quarter March -70.20 -34.82 -22.03 -11.66
FY   -70.20 -179.77 -87.50 -72.44



ATRA Free Cash Flow first quarter 2019 Y/Y Growth Comment
Atara Biotherapeutics, Inc. in the first quarter recorded free cash outflow of $ -70.20 millions.

According to the results reported in the first quarter, Atara Biotherapeutics, Inc. achieved the best Free Cash Flow growth in Biotechnology & Drugs industry. While Atara Biotherapeutics, Inc.' s Free Cash Flow no change of % ranks overall at the positon no. in the first quarter.




ATRA Free Cash Flow ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Atara Biotherapeutics,'s first quarter 2019 Free Cash Flow $ -70.20 millions ATRA's Income Statement
Atara Biotherapeutics,'s first quarter 2018 Free Cash Flow $ -34.82 millions Quarterly ATRA's Income Statement
New: More ATRA's historic Free Cash Flow Growth >>


ATRA Free Cash Flow (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Atara Biotherapeutics,'s Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's I. Quarter Q/Q Free Cash Flow Comment
I. Quarter 2019 results of -70.20 millions by Atara Biotherapeutics, Inc. come out even worse if you take a look at -57.42 millions free cash outflow a quarter before.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential Free Cash Flow growth. While Atara Biotherapeutics,'s Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's I. Quarter Q/Q Free Cash Flow Comment
Current accomplishment of -70.20 millions by Atara Biotherapeutics, Inc. look even more unfavourable if you take a look at -57.42 millions free cash outflow a quarter before.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential Free Cash Flow growth. While Atara Biotherapeutics,'s Free Cash Flow growth quarter on quarter, overall rank is .


Atara Biotherapeutics,'s 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
12 Months Ending
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Free Cash Flow 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment
In the period, Atara Biotherapeutics,'s cumulative trailing twelve month Free Cash Flow remained unchanged compare to the same period a year ago.

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment
In the period, Atara Biotherapeutics,'s cumulative trailing twelve month Free Cash Flow remained unchanged compare to the same period a year ago.

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Biotechnology & Drugs Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
ATRA's Free Cash Flow Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for ATRA's Competitors
Free Cash Flow Growth for Atara Biotherapeutics,'s Suppliers
Free Cash Flow Growth for ATRA's Customers

You may also want to know
ATRA's Annual Growth Rates ATRA's Profitability Ratios ATRA's Asset Turnover Ratio ATRA's Dividend Growth
ATRA's Roe ATRA's Valuation Ratios ATRA's Financial Strength Ratios ATRA's Dividend Payout Ratio
ATRA's Roa ATRA's Inventory Turnover Ratio ATRA's Growth Rates ATRA's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Mar 31 2019 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Mar 31 2019
Immucell Corp  171.25 %$ 171.246 millions
Voyager Therapeutics, Inc.  157.48 %$ 157.482 millions
Standard Diversified Inc.  150.87 %$ 150.873 millions
Icon Plc  133.85 %$ 133.849 millions
China Health Industries Holdings, Inc.  131.13 %$ 131.129 millions
Exelixis, Inc.  125.03 %$ 125.035 millions
Xtant Medical Holdings, Inc.  107.63 %$ 107.627 millions
Biotelemetry, Inc.  93.34 %$ 93.344 millions
Bio-techne Corp  83.20 %$ 83.196 millions
Zynex Inc  77.64 %$ 77.644 millions
Tearlab Corp  71.55 %$ 71.552 millions
Merit Medical Systems Inc  70.20 %$ 70.195 millions
Innoviva, Inc.  53.57 %$ 53.574 millions
Quest Diagnostics Inc  52.78 %$ 52.778 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GIGL's Profile

Stock Price

GIGL's Financials

Business Description

Fundamentals

Charts & Quotes

GIGL's News

Suppliers

GIGL's Competitors

Customers & Markets

Economic Indicators

GIGL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071